FR3010720B1 - Procede de production de virus enveloppes - Google Patents

Procede de production de virus enveloppes

Info

Publication number
FR3010720B1
FR3010720B1 FR1358909A FR1358909A FR3010720B1 FR 3010720 B1 FR3010720 B1 FR 3010720B1 FR 1358909 A FR1358909 A FR 1358909A FR 1358909 A FR1358909 A FR 1358909A FR 3010720 B1 FR3010720 B1 FR 3010720B1
Authority
FR
France
Prior art keywords
enveloped viruses
producing enveloped
producing
viruses
enveloped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1358909A
Other languages
English (en)
French (fr)
Other versions
FR3010720A1 (fr
Inventor
David Fenard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genethon
Original Assignee
Genethon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50424334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR3010720(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genethon filed Critical Genethon
Priority to FR1358909A priority Critical patent/FR3010720B1/fr
Priority to ES14796166T priority patent/ES2732154T3/es
Priority to CA2923554A priority patent/CA2923554C/fr
Priority to RU2016114541A priority patent/RU2016114541A/ru
Priority to EP14796166.8A priority patent/EP3047025B1/fr
Priority to JP2016542356A priority patent/JP6629210B2/ja
Priority to SG11201602017YA priority patent/SG11201602017YA/en
Priority to PCT/FR2014/052279 priority patent/WO2015036713A1/fr
Priority to CN201480050980.4A priority patent/CN105722984B/zh
Priority to DK14796166.8T priority patent/DK3047025T3/da
Priority to US15/022,049 priority patent/US10125352B2/en
Publication of FR3010720A1 publication Critical patent/FR3010720A1/fr
Publication of FR3010720B1 publication Critical patent/FR3010720B1/fr
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR1358909A 2013-09-16 2013-09-16 Procede de production de virus enveloppes Expired - Fee Related FR3010720B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR1358909A FR3010720B1 (fr) 2013-09-16 2013-09-16 Procede de production de virus enveloppes
SG11201602017YA SG11201602017YA (en) 2013-09-16 2014-09-12 Method for producing enveloped viruses
CN201480050980.4A CN105722984B (zh) 2013-09-16 2014-09-12 生产包膜病毒的方法
RU2016114541A RU2016114541A (ru) 2013-09-16 2014-09-12 Способ получения оболочечного вируса
EP14796166.8A EP3047025B1 (fr) 2013-09-16 2014-09-12 Procede de production de virus enveloppes
JP2016542356A JP6629210B2 (ja) 2013-09-16 2014-09-12 エンベロープウイルスの産生方法
ES14796166T ES2732154T3 (es) 2013-09-16 2014-09-12 Procedimiento de producción de virus envueltos
PCT/FR2014/052279 WO2015036713A1 (fr) 2013-09-16 2014-09-12 Procede de production de virus enveloppes
CA2923554A CA2923554C (fr) 2013-09-16 2014-09-12 Procede de production de virus enveloppes
DK14796166.8T DK3047025T3 (da) 2013-09-16 2014-09-12 Fremgangsmåde til fremstilling af kappevira
US15/022,049 US10125352B2 (en) 2013-09-16 2014-09-12 Method for producing enveloped viruses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1358909A FR3010720B1 (fr) 2013-09-16 2013-09-16 Procede de production de virus enveloppes

Publications (2)

Publication Number Publication Date
FR3010720A1 FR3010720A1 (fr) 2015-03-20
FR3010720B1 true FR3010720B1 (fr) 2017-08-11

Family

ID=50424334

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1358909A Expired - Fee Related FR3010720B1 (fr) 2013-09-16 2013-09-16 Procede de production de virus enveloppes

Country Status (11)

Country Link
US (1) US10125352B2 (enExample)
EP (1) EP3047025B1 (enExample)
JP (1) JP6629210B2 (enExample)
CN (1) CN105722984B (enExample)
CA (1) CA2923554C (enExample)
DK (1) DK3047025T3 (enExample)
ES (1) ES2732154T3 (enExample)
FR (1) FR3010720B1 (enExample)
RU (1) RU2016114541A (enExample)
SG (1) SG11201602017YA (enExample)
WO (1) WO2015036713A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes
HK1258932A1 (zh) 2015-10-22 2019-11-22 Juno Therapeutics Gmbh 用於转导的方法、反应剂盒、反应剂和设备
KR20220047635A (ko) 2019-08-23 2022-04-18 론자 워커스빌 아이엔씨. 렌티바이러스 벡터의 생산을 위한 방법 및 작제물
AU2022212090A1 (en) 2021-01-28 2023-07-06 Allogene Therapeutics, Inc. Methods for transducing immune cells
WO2023114949A1 (en) 2021-12-16 2023-06-22 Sana Biotechnology, Inc. Methods and systems of particle production

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5110696B2 (ja) 2004-11-05 2012-12-26 ウェルスタット バイオロジクス コーポレイション 安定かつ濾過可能なエンベロープで覆われたウイルス処方物
ATE539149T1 (de) 2006-04-20 2012-01-15 Wyeth Llc Reinigungsverfahren zur isolierung von gereinigtem vesikulärem stomatitisvirus aus zellkultur
WO2009153563A1 (en) 2008-06-18 2009-12-23 Oxford Biomedica (Uk) Limited Virus purification
JP6175055B2 (ja) * 2011-06-30 2017-08-02 ジェネトン ウイルス感染増強特性を有するペプチドおよびその使用
CN104136605B (zh) * 2011-11-24 2018-08-14 吉尼松公司 与工业制药应用相容的可放大的慢病毒载体生产系统
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes

Also Published As

Publication number Publication date
WO2015036713A1 (fr) 2015-03-19
JP6629210B2 (ja) 2020-01-15
EP3047025A1 (fr) 2016-07-27
US20160230147A1 (en) 2016-08-11
EP3047025B1 (fr) 2019-04-03
DK3047025T3 (da) 2019-06-24
CA2923554A1 (fr) 2015-03-19
CN105722984B (zh) 2021-08-13
SG11201602017YA (en) 2016-04-28
JP2016530890A (ja) 2016-10-06
RU2016114541A (ru) 2017-10-23
US10125352B2 (en) 2018-11-13
FR3010720A1 (fr) 2015-03-20
CN105722984A (zh) 2016-06-29
CA2923554C (fr) 2019-10-29
ES2732154T3 (es) 2019-11-20

Similar Documents

Publication Publication Date Title
EP2941442A4 (en) METHOD FOR PRODUCING MICROFIBRILLED CELLULOSE
IL244399A0 (en) Improved terpene-based compositions, processes, methodologies for creation and products thereby
EP3020688A4 (en) ZEOLITE PROCESS
HUE046414T2 (hu) Eljárás tagatóz elõállítására
EP3015467A4 (en) MORPHOLINE-OLIGONUCLEOTIDE METHOD
EP3006415A4 (en) PROCESS FOR PRODUCING NANOCEMENT AND NANOCEMENT
FR2986525B1 (fr) Procede de production de 2,3,3,3-tetrafluoropropene
EP2970170A4 (en) PROCESS FOR PREPARING 2,5-FURANDIC ACETIC ACID
EP2984064A4 (en) PROCESS FOR THE PREPARATION OF 1,4-BANDALIUM
EP3354730A4 (en) LINALOOLHERSTELLUNGSVERFAHREN
GB201310432D0 (en) Virus Production
EP2980084A4 (en) PROCESS FOR THE PRODUCTION OF GLYCOLIDE
FR3003861B1 (fr) Nouveau procede de preparation de polyols-glycosides
EP2939978A4 (en) PROCESS FOR PREPARING DIFLUORO PHOSPHATE
EP2980055A4 (en) PROCESS FOR THE PREPARATION OF 2,7-OCTADIEN-1-OL
EP2899157A4 (en) PREPARATION OF DIFLUORPHOSPHATE
EP2947101A4 (en) Method for producing polymer
EP2960338A4 (en) SUGAR SOLUTION PROCESS
EP2949639A4 (en) PREPARATION FOR ALPHA, ALPHA-DIFLUORACETALDEHYDE
ZA201508828B (en) Avian cells for improved virus production
FR2998290B1 (fr) Procede de potabilisation
EP2980053A4 (en) BUTADIENHERSTELLUNGSVERFAHREN
EP3023440A4 (en) POLYMER PRODUCTION PROCESS
BR112016009828A2 (pt) Processo de produção de propeno
FR2995231B1 (fr) Procede de trefilage

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20230505